Defying the weak broader market sentiment, shares of Sun Pharmaceutical and Coal India rose by three per cent each on the BSE today, after the exchange said it will include these two stocks in the BSE Sensex from August 8, 2011.Shares of Sun Pharma went up by three per cent to touch an early high of Rs. 493 on the Bombay Stock Exchange (BSE), while Coal India touched an early peak of Rs. 405.95, up three per cent from the previous close.Coal India and Sun Pharma will replace two Anil Ambani group firms -- Reliance Infrastructure and Reliance Communications in Sensex from August 8, 2011.The announcement was made after market hours on Friday. Coal India shares have been doing well since the company was listed in November last year and is the second most valued firm after Reliance Industries.Meanwhile, the BSE crucial index Sensex was trading down by 202.26 points at 17,668.27 at 1204 hours.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment